Which anaesthetic agents and techniques are most cost-effective in day surgery?
Not Applicable
Completed
- Conditions
- ot applicableNot Applicable
- Registration Number
- ISRCTN87609400
- Lead Sponsor
- Department of Health (UK)
- Brief Summary
2002 Results article in http://www.ncbi.nlm.nih.gov/pubmed/12709296 HTA monograph
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1760
Inclusion Criteria
Adult general, orthopaedic and gynaecology patients, and paediatric general and ear, nose and throat (ENT) patients.
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative nausea and vomiting (PONV)
- Secondary Outcome Measures
Name Time Method ot provided at time of registration
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of volatile anesthetics versus intravenous agents impact cost-effectiveness in day surgery?
How does regional anesthesia compare to general anesthesia in cost-effectiveness for day surgery patients according to UK guidelines?
What pharmacogenomic biomarkers predict response to anesthetic agents in day surgery?
What adverse events were reported in ISRCTN87609400 and how were they managed in day surgery?
What combination of propofol and local anesthetics improves cost-effectiveness in day surgery per ISRCTN87609400?